|
RMS Describing, Resampling, Validating, and Simplifying the Model
|
|
158
|
39679
|
April 4, 2024
|
|
Run-in phase in RCTs
|
|
14
|
9650
|
April 1, 2024
|
|
Relationship between Probabilistic Index and Common Odds Ratio
|
|
1
|
121
|
April 1, 2024
|
|
RMS Titanic Binary Logistic Case Study
|
|
9
|
13711
|
March 28, 2024
|
|
External validation of a time-to-event prognostic model
|
|
1
|
217
|
March 26, 2024
|
|
Numerical Differences in Survival Probability Estimates between coxph and cph Functions
|
|
8
|
617
|
March 24, 2024
|
|
Individual response
|
|
236
|
34510
|
March 24, 2024
|
|
Redundancy analysis of covariates in a Cox model using flexible parametric additive models
|
|
9
|
525
|
March 22, 2024
|
|
Progression in cancer trials
|
|
25
|
3357
|
March 22, 2024
|
|
Validate and calibrate Cox model on dataset with a categorical covariate with few observations
|
|
2
|
217
|
March 21, 2024
|
|
Calculate incidence rate after adjustment
|
|
10
|
1301
|
March 19, 2024
|
|
Choosing variables for mutivariable survival prediction
|
|
21
|
3708
|
March 18, 2024
|
|
Executable Specification of Dose Escalation Oncology Protocol now on Arxiv
|
|
2
|
198
|
March 16, 2024
|
|
Bayesian vs. Frequentist Statements About Treatment Efficacy
|
|
0
|
1346
|
September 4, 2022
|
|
Model Performance with Repeat Predictions
|
|
10
|
278
|
March 12, 2024
|
|
External Validation and Calibration of Cox model
|
|
13
|
5111
|
March 12, 2024
|
|
Communicating statistical concerns to the FDA
|
|
3
|
379
|
March 11, 2024
|
|
Retrospective discussion on the ALS drug, RELYVRIO
|
|
0
|
254
|
March 10, 2024
|
|
Tresholds in bayesian designs
|
|
0
|
122
|
March 6, 2024
|
|
Random effects in mixed-effect multivariable logistic regression models
|
|
0
|
214
|
March 5, 2024
|
|
RMS Ordinal Logistic Regression
|
|
34
|
13944
|
March 3, 2024
|
|
Statistical Parameter Mapping
|
|
4
|
263
|
February 28, 2024
|
|
Percentage as a measure of a predictor variable
|
|
7
|
430
|
February 27, 2024
|
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
352
|
February 23, 2024
|
|
Evaluating seizures in open-label studies
|
|
5
|
249
|
February 20, 2024
|
|
Prior design in a bayesian re-analysis of an RCT
|
|
1
|
247
|
February 19, 2024
|
|
Problems with NNT
|
|
36
|
33005
|
February 19, 2024
|
|
Assessing correlation/surrogacy between 2 estimated treatment effects
|
|
9
|
457
|
February 17, 2024
|
|
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic
|
|
34
|
2877
|
February 16, 2024
|
|
RCT: protocol deviation and implications for analysis
|
|
6
|
343
|
February 16, 2024
|